REFERENCES
- Haupert CL, Jaffe GJ. New and emerging treatments for patients with uveitis. Int Ophthalmol Clinic. 2000; 40(2): 205–220.
- Jaffe GJ, Martin DM, Callanan D, Pearson A, Levy B, Comstock T. Fluocinolone acetonide implant (Retisert™) for noninfectious posterior uveitis: thirty-four week results of a multicenter randomized clinical study. Ophthalmology. 2006; 113(6): 1020–1027.
- Retisert™ (fluocinolone acetonide intravitreal implant) formulary kit. Rochester, NY: Bausch & Lomb; May 2005.
- Srivastava SK, Martin DF, Mellow SD, et al. Pathological findings in eyes with the ganciclovir implant. Ophthalmology. 2005; 112(5): 780–786.
- Taban M, Lowder CY, Kaiser PK. Outcome of fluocinolone acetonide implant (Retisert™) reimplantation for chronic noninfectious posterior uveitis. Retina. 2008; 28(9): 1284.